increased length of allograft survival_Ccl17<tm1.1Ifo>/Ccl17<tm1.1Ifo>

http://metadb.riken.jp/0004751I129P2OlaHsdC57BL6Ccl17tm11IfoCcl17tm11IfoCcl17tm11Ifo

increased length of allograft survival_Ccl17<tm1.1Ifo>/Ccl17<tm1.1Ifo>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• chemokine (C-C motif) ligand 17
  http://metadb.riken.jp/db/mgi_rdf/MGI:1329039

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Ccl17<tm1.1Ifo>/Ccl17<tm1.1Ifo>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Ccl17<tm1.1Ifo>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased length of allograft survival
  http://purl.obolibrary.org/obo/MP_0004751

文献

http://purl.org/net/cito/citesAsAuthority

• Judith. Alferink, et.al., Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen., The Journal of experimental medicine, 2003, 197
  http://rdf.ncbi.nlm.nih.gov/pubmed/12615900